Walpen S - Search Results

1

Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patients.

Ketteler M, Sprague SM, Covic AC, Rastogi A, Spinowitz B, Rakov V, Walpen S, Floege J. Ketteler M, et al. Among authors: walpen s. Nephrol Dial Transplant. 2019 Jul 1;34(7):1163-1170. doi: 10.1093/ndt/gfy127. Nephrol Dial Transplant. 2019. PMID: 29846719 Free PMC article. Clinical Trial.

2

Long-term efficacy and safety of sucroferric oxyhydroxide in African American dialysis patients.

Sprague SM, Ketteler M, Covic AC, Floege J, Rakov V, Walpen S, Rastogi A. Sprague SM, et al. Among authors: walpen s. Hemodial Int. 2018 Oct;22(4):480-491. doi: 10.1111/hdi.12663. Epub 2018 Apr 15. Hemodial Int. 2018. PMID: 29656600 Clinical Trial.

3

Iron kinetics following treatment with sucroferric oxyhydroxide or ferric citrate in healthy rats and models of anaemia, iron overload or inflammation.

Floege J, Funk F, Ketteler M, Rastogi A, Walpen S, Covic AC, Sprague SM. Floege J, et al. Among authors: walpen s. Nephrol Dial Transplant. 2020 Jun 1;35(6):946-954. doi: 10.1093/ndt/gfaa030. Nephrol Dial Transplant. 2020. PMID: 32259248 Free PMC article.

4

Characteristics of Patients Who Achieve Serum Phosphorus Control on Sucroferric Oxyhydroxide or Sevelamer Carbonate: A post hoc Analysis of a Phase 3 Study.

Covic AC, Sprague SM, Rastogi A, Ketteler M, Walpen S, Perrin A, Floege J. Covic AC, et al. Among authors: walpen s. Nephron. 2020;144(9):428-439. doi: 10.1159/000507258. Epub 2020 Jun 25. Nephron. 2020. PMID: 32585670 Free PMC article. Clinical Trial.

5

Impact of longer term phosphorus control on cardiovascular mortality in hemodialysis patients using an area under the curve approach: results from the DOPPS.

Lopes MB, Karaboyas A, Bieber B, Pisoni RL, Walpen S, Fukagawa M, Christensson A, Evenepoel P, Pegoraro M, Robinson BM, Pecoits-Filho R. Lopes MB, et al. Among authors: walpen s. Nephrol Dial Transplant. 2020 Oct 1;35(10):1794-1801. doi: 10.1093/ndt/gfaa054. Nephrol Dial Transplant. 2020. PMID: 32594171 Free PMC article.

6

Renoprotective effects of sucroferric oxyhydroxide in a rat model of chronic renal failure.

Neven E, Corremans R, Vervaet BA, Funk F, Walpen S, Behets GJ, D'Haese PC, Verhulst A. Neven E, et al. Among authors: walpen s. Nephrol Dial Transplant. 2020 Oct 1;35(10):1689-1699. doi: 10.1093/ndt/gfaa080. Nephrol Dial Transplant. 2020. PMID: 33022710 Free PMC article.

7

The real-world effectiveness of sucroferric oxyhydroxide in European hemodialysis patients: a 1-year retrospective database analysis.

Ramos R, Chazot C, Ferreira A, Di Benedetto A, Gurevich K, Feuersenger A, Wolf M, Arens HJ, Walpen S, Stuard S. Ramos R, et al. Among authors: walpen s. BMC Nephrol. 2020 Dec 7;21(1):530. doi: 10.1186/s12882-020-02188-8. BMC Nephrol. 2020. PMID: 33287733 Free PMC article.

8

Real-world safety and effectiveness of sucroferric oxyhydroxide for treatment of hyperphosphataemia in dialysis patients: a prospective observational study.

Vervloet MG, Boletis IN, de Francisco ALM, Kalra PA, Ketteler M, Messa P, Stauss-Grabo M, Derlet A, Walpen S, Perrin A, Ficociello LH, Rottembourg J, Wanner C, Cannata-Andía JB, Fouque D. Vervloet MG, et al. Among authors: walpen s. Clin Kidney J. 2021 Feb 5;14(7):1770-1779. doi: 10.1093/ckj/sfaa211. eCollection 2021 Jul. Clin Kidney J. 2021. PMID: 34221384 Free PMC article.

9

Estimating hospital inpatient cost-savings with sucroferric oxyhydroxide in patients on chronic hemodialysis in five European countries: a cost analysis.

Herrero JA, Salomone M, Ramirez de Arellano A, Schaufler T, Walpen S. Herrero JA, et al. Among authors: walpen s. J Med Econ. 2021 Jan-Dec;24(1):1240-1247. doi: 10.1080/13696998.2021.1996957. J Med Econ. 2021. PMID: 34761724 Free article.

10

Efficacy and Safety of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in Chinese Dialysis Patients with Hyperphosphataemia: A Randomised, Open-Label, Multicentre, 12-Week Phase III Study.

Liu J, Zuo L, Walpen S, Bernard L, Marty M, Enoiu M. Liu J, et al. Among authors: walpen s. Nephron. 2024;148(1):22-33. doi: 10.1159/000531869. Epub 2023 Jul 20. Nephron. 2024. PMID: 37473746 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters